Symptomatic treatment

Symptomatic treatment of Fabry disease requires a multidisciplinary approach as a result of the varied nature of symptoms; multiple, concomitant treatments are therefore usually necessary.1 Organ function, symptom control and psychosocial aspects of the condition all require consideration.1 The table below outlines the most common symptomatic and/or concomitant treatments for patients.

Symptomatic treatments used in Fabry disease

SIGN OR SYMPTOMTREATMENT(S) USED
Cardiovascular diseaseChest pain: Anti-angina drugs (beta-blockers, calcium antagonists, nitrates) Heart failure: Diuretics, angiotensinconverting enzyme (ACE) inhibitors, digoxin Abnormal heart rhythms: Anti-arrhythmic drugs, anti-coagulating drugs, implantable cardioverter or defibrillator Bradycardia (slow heart beat): Pacemaker
Renal diseaseProteinuria: ACE inhibitors, angiotensin receptor blockers (ARBs) Renal failure: Dialysis, transplantation
PainChronic pain: Anticonvulsants (e.g. carbamazepine, phenytoin, gabapentin) Painful crises: Non-steroidal anti-inflammatory drugs, opiates
Gastrointestinal symptomsNausea and vomiting: Anti-emetics (e.g. metoclopramide) Diet and nutrition: Low-fat diet, oral nutritional formula, motility agents, pancreatic enzyme supplements
Skin lesions (angiokeratoma)Removal with argon laser therapy
Sweating abnormalities (hypohidrosis oranhidrosis)Washing in cool water, use of a fan, cold drinks, limitation of physical activity
Neurovascular diseaseAspirin, clopidogrel (oral anti-platelet drug that reduces the risk of blood clotting; also given after a stroke or a heart attack)
Hypertension (high blood pressure)Rigorous control (e.g. with ACE inhibitors; beta-blockers should be avoided if bradycardia is present)
Hyperlipidaemia (high levels of total cholesterol, low-density lipoprotein cholesterol, triglycerides, or both total cholesterol and triglyceride)Statins (cholesterol-lowering drugs)
Table reproduced with kind permission from Dr Derralyn Hughes1

View references

Sign up to receive more information about Anderson-Fabry Disease

First Name
Last Name
Email
Country
Speciality

With your permission, Shire would like to contact you by electronic means (such as email or SMS) with information about products and services that we feel may be of interest to you. You have the right to opt out of receiving such electronic communications, at any time, by contacting us. Depending on the country you reside in, Shire may be required by law to obtain your consent in order to be able to send such electronic communications to you.

I consent to be contacted by Shire by electronic means with information about Shire's products and services.
We encourage you to read our privacy policy.

Start typing and press Enter to search